Durvalumab as neoadjuvant therapy for muscle-invasive bladder cancer: Preliminary results from the Bladder Cancer Signal Seeking Trial (BLASST)-2.Xiao X. Wei, Guru Sonpavde, Richard J. Lee et al.|Journal of Clinical Oncology|2020Cited by 20